Could a simpler hormone regimen boost IVF success? new trial investigates

NCT ID NCT06644794

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial compares two ways to prepare the womb lining for a frozen embryo transfer: a modified natural cycle using progesterone only, versus standard hormone replacement therapy. The study will enroll 336 women aged 21-44 with regular cycles to see which method leads to more live births. The modified natural cycle aims to be more convenient and potentially safer by reducing the need for monitoring and lowering pregnancy complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Progesterone and estradiol (hormone therapies)
What this could lead to
If this trial succeeds, it could show that a simpler, more natural hormone preparation method leads to more live births and fewer pregnancy complications for women undergoing frozen embryo transfer.
What could go wrong
This is a phase 3 trial, but it is still relatively small (336 participants) and focuses on a specific group of women with regular cycles. Results may not apply to all infertility patients, and the new method may not prove superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Shandong University of Traditional Chinese Medicine

    RECRUITING

    Jinan, Shandong, 250014, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.